Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy Study in Adult Subjects With Acute Migraines

ClinicalTrials.gov ID: NCT03235479

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03235479. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 17, 2026, 10:57 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the efficacy of BHV-3000 (rimegepant) versus placebo in subjects with Acute Migraines

Study identification

NCT ID
NCT03235479
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
1,485 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 18, 2017 (Actual)
Primary completion
Jan 21, 2018 (Actual)
Completion
Jan 26, 2018 (Actual)
Last update posted
Feb 16, 2023

2017 – 2018

United States locations

U.S. sites
50
U.S. states
26
U.S. cities
48
Facility City State ZIP Site status
Central Research Associates, Inc Birmingham Alabama 35205 —
Neurological Physicians of Arizona/Radiant Research Inc Gilbert Arizona 85282 —
Clinical Research Consortium Arizona Tempe Arizona 85283 —
Radiant Research, Inc. Tucson Arizona 85712 —
Woodland International Research Group, LLC Little Rock Arkansas 72211 —
Pharmacology Research Institute Encino California 91316 —
Optimus Medical Group San Francisco California 94102 —
California Medical Clinic for Headache Santa Monica California 90404 —
Diablo Clinical Research, Inc Walnut Creek California 94598 —
Qps Mra, Llc Hollywood Florida 33024 —
Multi-Specialty Research Associates, Inc Lake City Florida 32055 —
Qps Mra, Llc Miami Florida 33143 —
Advanced Pharma CR, LLC Miami Florida 33147 —
Compass Research, LLC Orlando Florida 32806 —
Ormond Medical Arts Pharmaceutical Research Ormond Beach Florida 32174 —
Meridian Clinical Research Savannah Georgia 31406 —
New Orleans Center for Clinical Research New Orleans Louisiana 70119 —
Boston Clinical Trials, Inc Boston Massachusetts 02131 —
Milford Emergency Associates, Inc. Marlborough Massachusetts 01752 —
Michigan Head Pain & Neurological Institute Ann Arbor Michigan 48104 —
Clinical Research Institute, Inc Minneapolis Minnesota 55402 —
Clinical Research Institute Minneapolis Minnesota 55402 —
The Center for Pharmaceutical Research Kansas City Missouri 64114 —
Sundance Clinical Research, LLC St Louis Missouri 63141 —
Meridian Clinical Research -Norfolk Norfolk Nebraska 68701 —
Meridian Clinical Research, LLC Omaha Nebraska 68134 —
Clinical Research Consortium- Las Vegas Las Vegas Nevada 89119 —
Hassman Research Institute, LLC Berlin New Jersey 08009 —
SPRI Clinical Trials, LLC Brooklyn New York 11235 —
Regional Clinical Research, Inc. Endwell New York 13760 —
Central New York Clinical Research Manlius New York 13104 —
Fieve Clinical Research New York New York 10168 —
Rochester Clinical Research, Inc Rochester New York 14609 —
PharmQuest, LLC Greensboro North Carolina 27408 —
CTI Clinical Research Center Cincinnati Ohio 45227 —
Oregon Center for Clinical Investigations, Inc Portland Oregon 97214 —
Clinical Research of Philadelphia, LLC Philadelphia Pennsylvania 19114-1029 —
Preferred Primary Care Physicians Uniontown Pennsylvania 15401 —
Omega Medical Research Warwick Rhode Island 02886 —
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464 —
Meridian Clinical Research Dakota Dunes South Dakota 57409 —
FutureSearch Trials of Neurology, LP Austin Texas 78731 —
FutureSearch Trials of Neurology, LP Dallas Texas 75231 —
Texas Center for Drug Development Houston Texas 77081 —
J.Lewis Research Inc / Foothill Family Clinic South Salt Lake City Utah 84121 —
J.Lewis Research Inc. / Jordan River Family Med South Jordan Utah 84095 —
Clinical Research Associates of Tidewater, Inc. Norfolk Virginia 23507 —
Tidewater Integrated Medical Research Virginia Beach Virginia 23454 —
Northwest Clinical Research Center Bellevue Washington 98007 —
Seattle Women's:Health, Research & Gynecology Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03235479, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 16, 2023 · Synced Nov 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.